Meet us in:
Galgo Medical signs a collaboration agreement with the Hospital of the University of Pennsylvania to evaluate ADAS.
Jacobo Gil de Biedma joins Galgo as Director of Business Development.
Galgo Medical recently named Mr Jacobo Gil de Biedma as its new Director of Business Development.
Inveready enters the capital of Galgo Medical.
The venture capital firm Inveready participates in a round of 1million Euros for the medical software company Galgo Medical to move forward with its development and marketing efforts of its three product lines.
Galgo, Clínic, UPF & UB signed a collaboration agreement for cardiac arrhthmia development.
Hospital Clínic de Barcelona, Universitat Pompeu Fabra (UPF) and Universitat de Barcelona (UB) signed a collaboration agreement with Galgo Medical SL for the development of technologies to identify the cause of cardiac arrhythmias and facilitate their treatment.
SYLVIUS Project Collaboration Agreement with IMIM signed.
Institut Hospital del Mar d’Investigacions Biomèdiques (IMIM) signed a collaboration agreement with Galgo Medical SL for the development of the project SYLVIUS for the development of software tools to predict language function for optimal surgical strategy.
French CIR qualification granted.
Galgo Medical obtained the CIR qualification granted by the French Administration in recognition as an intensive research and development (R&D) SME. The qualification is granted for a period of two years.